The federal contract award is for the delivery of BOTOX 200 unit vials to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $63,236.25 and an ultimate completion date of January 7, 2025. The contract was awarded on December 13, 2024 and was not set aside for any specific business type. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM.gov) and has extensive experience providing pharmaceutical products and medical supplies to federal healthcare programs, particularly within military and veterans' healthcare systems. The contract is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 3/14/25, 10:05 AM